PIPERIDINYL DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
1 Assignment
0 Petitions
Accused Products
Abstract
The present application describes substituted piperidinyl modulators of MIP-1α or CCR-1 or stereoisomers or pharmaceutically acceptable salts thereof. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and transplant rejection using said modulators are disclosed.
-
Citations
33 Claims
-
1. A compound of Formula (I):
- View Dependent Claims (2, 3, 4, 5, 6, 7, 26, 27)
-
2. The compound of claim 1, wherein the compound is a compound of formula (Ia):
-
3. The compound of claim 2, wherein:
-
4. The compound of claim 2, wherein:
-
5. The compound of claim 2, wherein:
-
6. The compound of claim 2, wherein:
-
7. The compound of claim 2, wherein:
-
26. A pharmaceutical composition comprised of a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one compound of claim 1.
-
27. A method for treating a disorder comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of claim 1, wherein said disorder is selected from osteoarthritis, aneurysm, fever, cardiovascular effects, Crohn'"'"'s disease, congestive heart failure, autoimmune diseases, HIV-infection, HIV-associated dementia, psoriasis, idiopathic pulmonary fibrosis, transplant arteriosclerosis, physically- or chemically-induced brain trauma, inflammatory bowel disease, alveolitis, colitis, systemic lupus erythematosus, nephrotoxic serum nephritis, glomerularnephritis, asthma, multiple sclerosis, artherosclerosis, rheumatoid arthritis, restinosis, organ transplantation, psoriatic arthritis, multiple myeloma, allergies, hepatocellular carcinoma, osteoporosis, renal fibrosis and cancer.
-
2. The compound of claim 1, wherein the compound is a compound of formula (Ia):
-
8. A compound of Formula (Ib):
- View Dependent Claims (9, 10, 11, 12, 13, 14, 15, 16, 28, 29)
-
9. The compound of claim 8, wherein the compound is a compound of formula (Ib′
- );
- );
-
10. The compound of claim 9, wherein:
-
11. The compound of claim 9, wherein:
-
12. The compound of claim 9, wherein:
-
13. The compound of claim 9, wherein:
-
14. The compound of claim 9, wherein:
-
15. The compound of claim 9, wherein R2 is isopropyl, sec-butyl or cyclopropyl;
- R4 is methyl;
R5 is Cl, F or Br; and
R1 is alkyl, cycloalkyl, aryl or heteroaryl, all of which may be optionally substituted with 0-5 R1a.
- R4 is methyl;
-
16. The compound of claim 15, wherein:
-
28. A pharmaceutical composition comprised of a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one compound of claim 9.
-
29. A method for treating a disorder comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of claim 9, wherein said disorder is selected from osteoarthritis, aneurysm, fever, cardiovascular effects, Crohn'"'"'s disease, congestive heart failure, autoimmune diseases, HIV-infection, HIV-associated dementia, psoriasis, idiopathic pulmonary fibrosis, transplant arteriosclerosis, physically- or chemically-induced brain trauma, inflammatory bowel disease, alveolitis, colitis, systemic lupus erythematosus, nephrotoxic serum nephritis, glomerularnephritis, asthma, multiple sclerosis, artherosclerosis, rheumatoid arthritis, restinosis, organ transplantation, psoriatic arthritis, multiple myeloma, allergies, hepatocellular carcinoma, osteoporosis, renal fibrosis and cancer.
-
9. The compound of claim 8, wherein the compound is a compound of formula (Ib′
-
17. A compound of formula (Ic):
- View Dependent Claims (18, 19, 20, 21, 22, 23, 30, 31)
-
18. The compound of claim 17, wherein the compound is a compound of formula (Id):
-
19. The compound of claim 17, wherein:
-
R15 is —
NHR1, heteroaryl or aryl, wherein the heteroaryl and aryl may be optionally substituted with 0-3 R1a;R1 is aryl or heteroaryl, both of which may be optionally substituted with 0-3 R1a; R1a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, —
S(O)2NR9C(O)R6, aryloxy or arylalkyl, wherein the aryl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, aryloxy and arylalkyl may be optionally substituted with 0-3 R1b;R1b, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, aryloxy or arylalkyl;R2 is alkyl or cycloalkyl, wherein the alkyl may be optionally substituted with —
OH;R4, at each occurrence, is F, —
OH or alkyl;
or any two alkyl R4'"'"'s attached to the same carbon atom may form a 3- to 6-membered ring, which optionally may contain 1-4 heteroatoms selected from N, O, and S;W is hydrogen, F, or —
OH;R5 is halo, —
CN or —
Oalkyl;R6, at each occurrence, is independently alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R8, at each occurrence, is independently hydrogen or alkyl; R9, at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl, wherein the aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-5 R9a, and the heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R9a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R10, at each occurrence, is independently selected from alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl, wherein the alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-3 R10a, and the heterocyclyl and heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R10a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R14, at each occurrence, is independently selected from hydrogen, alkyl, cycloalkyl or phenyl; m, at each occurrence, is 0-2; n is 1-2; and r is 0-4.
-
-
20. The compound of claim 17, wherein:
-
R15 is —
NHR1, heteroaryl or aryl, wherein the heteroaryl and aryl may be optionally substituted with 0-3 R1a;R1 is aryl or heteroaryl, which may be optionally substituted with 0-3 R1a; R1a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, —
S(O)2NR9C(O)R6, aryloxy or arylalkyl, wherein the aryl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, aryloxy and arylalkyl may be optionally substituted with 0-3 R1b;R1b, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R9, aryloxy or arylalkyl;R2 is alkyl or cycloalkyl, wherein the alkyl may be optionally substituted with —
OH;R4, at each occurrence, is OH or alkyl;
or any two alkyl R4'"'"'s attached to the same carbon atom may form a 3- to 6-membered ring, which optionally may contain 1-4 heteroatoms selected from N, O, and S;W is hydrogen or —
OH;R5 is halo or —
CN;R6, at each occurrence, is independently alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R8, at each occurrence, is independently hydrogen or alkyl; R9, at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl, wherein the aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-5 R9a, and the heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R9a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R10, at each occurrence, is independently selected from alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl, wherein the alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-3 R10a, and the heterocyclyl and heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R10a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R14, at each occurrence, is independently selected from hydrogen, alkyl, cycloalkyl or phenyl; m, at each occurrence, is 0-2; n is 1-2; and r is 0-3.
-
-
21. The compound of claim 17, wherein:
-
R15 is —
NHR1, heteroaryl or aryl, wherein the heteroaryl and aryl may be optionally substituted with 0-3 R1a;R1 is aryl or heteroaryl, which may be optionally substituted with 0-3 R1a; R1a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, —
S(O)2NR9C(O)R6, aryloxy or arylalkyl, wherein the aryl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, aryloxy and arylalkyl may be optionally substituted with 0-3 R1b;R1b, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, aryloxy or arylalkyl;R2 is alkyl or cycloalkyl, wherein the alkyl may be optionally substituted with —
OH;R4, at each occurrence, is alkyl;
or any two R4'"'"'s attached to the same carbon atom may form a 3- to 6-membered ring, which optionally may contain 1-4 heteroatoms selected from N, O, and S;W is hydrogen or —
OH;R5 is halo; R6, at each occurrence, is independently alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R8, at each occurrence, is independently hydrogen or alkyl; R9, at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl, wherein the aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-5 R9a, and the heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R9a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R10, at each occurrence, is independently selected from alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl, wherein the alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-3 R10a, and the heterocyclyl and heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R10a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R14, at each occurrence, is independently selected from hydrogen, alkyl, cycloalkyl or phenyl; m, at each occurrence, is 0-2; n is 1-2; and r is 0-2.
-
-
22. The compound of claim 17, wherein:
-
R15 is —
NHR1 or heteroaryl, wherein the heteroaryl may be optionally substituted with 0-3 R1a;R1 is aryl or heteroaryl, which may be optionally substituted with 0-3 R1a; R1a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, —
S(O)2NR9C(O)R6, aryloxy or arylalkyl, wherein the aryl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, aryloxy and arylalkyl may be optionally substituted with 0-3 R1b;R1b, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R9, aryloxy or arylalkyl;R2 is alkyl or cycloalkyl, wherein the alkyl may be optionally substituted with —
OH;R4, at each occurrence, is alkyl; W is hydrogen or —
OH;R5 is halo; R6, at each occurrence, is independently alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R8, at each occurrence, is independently hydrogen or alkyl; R9, at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl, wherein the aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-5 R9a, and the heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R9a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R10, at each occurrence, is independently selected from alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl, wherein the alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-3 R10a, and the heterocyclyl and heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R10a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R14, at each occurrence, is independently selected from hydrogen, alkyl, cycloalkyl or phenyl; m, at each occurrence, is 0-2; n is 1-2; and r is 0-2.
-
-
23. The compound of claim 17, wherein:
-
R15 is —
NHR1;R1 is aryl or heteroaryl, which may be optionally substituted with 0-3 R1a; R1a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, —
S(O)2NR9C(O)R6, aryloxy or arylalkyl, wherein the aryl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, aryloxy and arylalkyl may be optionally substituted with 0-3 R1b;R1b, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR10, —
O(CF2)rCF3, —
O(CR8R8)rR10, —
OH, —
SH, —
S(CR8R8)rR10, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR9R9, —
NR9R9, —
S(O)2NR9R9, —
NR9S(O)2(CF2)rCF3, —
C(═
O)NR9S(O)2R6, —
S(O)2NR9C(═
O)OR6, —
S(O)2NR9C(═
O)NR9R9, —
C(═
O)NR9S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR10, —
NR9C(═
O)H, —
NR9C(═
O)(CR8R8)rR10, —
OC(═
O)(CR8R8)rR10, —
C(═
NR14)NR9R9, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR10, —
S(O)2(CR8R8)rR10, —
NR9C(═
O)OR8, —
NR9S(O2)R8, aryloxy or arylalkyl;R2 is alkyl or cycloalkyl; R4, at each occurrence, is alkyl; W is hydrogen or —
OH;R5 is halo; R6, at each occurrence, is independently alkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl; R8, at each occurrence, is independently hydrogen or alkyl; R9, at each occurrence, is independently hydrogen, alkyl, cycloalkyl, aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl, wherein the aryl, arylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-5 R9a, and the heteroaryl, heteroarylalkyl, heterocyclyl or heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R9a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR3R8)rR14, —
S(O)2(CR3R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R10, at each occurrence, is independently selected from alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl, wherein the alkyl, aryl, arylalkyl, heterocyclyl or heterocyclylalkyl may be optionally substituted with 0-3 R10a, and the heterocyclyl and heterocyclylalkyl contain 1-4 heteroatoms selected from N, O, and S; R10a, at each occurrence, is independently selected from alkyl, haloalkyl, aryl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, heteroaryl, heteroarylalkyl, heterocyclyl heterocyclylalkyl, halo, —
NH2, —
CN, —
NO2, —
C(═
O)OH, —
C(═
O)O(CR8R8)rR14, —
O(CF2)rCF3, —
O(CR8R8)rR14, —
OH, —
SH, —
S(CR8R8)rR14, —
S(O)3H, —
P(O)3H2, —
C(═
O)NR14R14, —
NR14R14, —
S(O)2NR14R14, —
NR14S(O)2(CF2)rCF3, —
C(═
O)NR14S(O)2R6, —
S(O)2NR14C(═
O)OR6, —
S(O)2NR14C(═
O)NR14R14, —
C(═
O)NR14S(O)2(CF2)rCF3, —
C(═
O)(CR8R8)rR14, —
NR14C(═
O)H, —
NR14C(═
O)(CR8R8)rR14, —
OC(═
O)(CR8R8)rR14, —
C(═
NR14)NR14R14, —
NHC(═
NR14)NR14R14, —
S(═
O)(CR8R8)rR14, —
S(O)2(CR8R8)rR14, —
NR14C(═
O)OR8, —
NR14S(O2)R8, aryloxy or arylalkyl;R14, at each occurrence, is independently selected from hydrogen, alkyl, cycloalkyl or phenyl; m, at each occurrence, is 0-2; n is 1-2; and r is 0-2.
-
-
30. A pharmaceutical composition comprised of a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one compound of claim 17.
-
31. A method for treating a disorder comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of claim 17, wherein said disorder is selected from osteoarthritis, aneurysm, fever, cardiovascular effects, Crohn'"'"'s disease, congestive heart failure, autoimmune diseases, HIV-infection, HIV-associated dementia, psoriasis, idiopathic pulmonary fibrosis, transplant arteriosclerosis, physically- or chemically-induced brain trauma, inflammatory bowel disease, alveolitis, colitis, systemic lupus erythematosus, nephrotoxic serum nephritis, glomerularnephritis, asthma, multiple sclerosis, artherosclerosis, rheumatoid arthritis, restinosis, organ transplantation, psoriatic arthritis, multiple myeloma, allergies, hepatocellular carcinoma, osteoporosis, renal fibrosis and cancer.
-
18. The compound of claim 17, wherein the compound is a compound of formula (Id):
-
24. A compound of Formula (Ie):
- View Dependent Claims (32, 33)
-
32. A pharmaceutical composition comprised of a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one compound of claim 24.
-
33. A method for treating a disorder comprising administering to a patient in need thereof a therapeutically effective amount of at least one compound of claim 24, wherein said disorder is selected from osteoarthritis, aneurysm, fever, cardiovascular effects, Crohn'"'"'s disease, congestive heart failure, autoimmune diseases, HIV-infection, HIV-associated dementia, psoriasis, idiopathic pulmonary fibrosis, transplant arteriosclerosis, physically- or chemically-induced brain trauma, inflammatory bowel disease, alveolitis, colitis, systemic lupus erythematosus, nephrotoxic serum nephritis, glomerularnephritis, asthma, multiple sclerosis, artherosclerosis, rheumatoid arthritis, restinosis, organ transplantation, psoriatic arthritis, multiple myeloma, allergies, hepatocellular carcinoma, osteoporosis, renal fibrosis and cancer.
-
32. A pharmaceutical composition comprised of a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one compound of claim 24.
-
25. A compound selected from the compounds exemplified in the examples.
Specification
- Resources
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeBristol-Myers Squibb Company
-
Original AssigneeBristol-Myers Squibb Company
-
InventorsCarter, Percy H., Hynes, John, Cavallaro, Cullen L., Santella, Joseph B., Gardner, Daniel S., Liu, Rui-Qin, Duncia, John V., Dodd, Dharmpal S.
-
Granted Patent
-
Time in Patent OfficeDays
-
Field of Search
-
US Class Current514/317
-
CPC Class CodesA61P 1/04 for ulcers, gastritis or re...A61P 1/16 for liver or gallbladder di...A61P 11/00 Drugs for disorders of the ...A61P 11/06 AntiasthmaticsA61P 13/12 of the kidneysA61P 17/06 AntipsoriaticsA61P 19/00 Drugs for skeletal disordersA61P 19/02 for joint disorders, e.g. a...A61P 19/10 for osteoporosisA61P 25/00 Drugs for disorders of the ...A61P 25/28 for treating neurodegenerat...A61P 29/00 Non-central analgesic, anti...A61P 31/18 for HIVA61P 35/00 Antineoplastic agentsA61P 37/00 Drugs for immunological or ...A61P 37/02 ImmunomodulatorsA61P 37/06 Immunosuppressants, e.g. dr...A61P 37/08 Antiallergic agents antiast...A61P 9/00 Drugs for disorders of the ...A61P 9/04 Inotropic agents, i.e. stim...A61P 9/10 : for treating ischaemic or a...C07D 211/18 : with substituted hydrocarbo...C07D 211/38 : Halogen atoms or nitro radi...C07D 211/52 : having an aryl radical as t...C07D 211/58 : attached in position 4C07D 211/70 : with only hydrogen atoms, h...C07D 401/12 : linked by a chain containin...C07D 401/14 : containing three or more he...C07D 405/12 : linked by a chain containin...C07D 409/12 : linked by a chain containin...C07D 413/12 : linked by a chain containin...C07D 417/12 : linked by a chain containin...C07D 417/14 : containing three or more he...C07D 471/04 : Ortho-condensed systemsC07D 487/04 : Ortho-condensed systemsC07D 491/10 : Spiro-condensed systemsC07D 491/107 : with only one oxygen atom a...